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a b s t r a c t   Despite the volume of biomedical and psychosocial discourse 
surrounding both renal transplantation and the immune system, there is a limit 
to current understandings of immunosuppression in the context of kidney 
transplantation. For example, we do not know how the immunosuppressed 
renal transplant recipient experiences and understands their immune system 
and body. In addition, we do not know if the patient is as ﬁ xated on ‘graft 
survival’ as their healthcare team or whether other concerns are more relevant. 
What is missing is the discourse of those who actually ‘live’ the medically 
altered immune system in the context of renal transplantation.
We propose that this gap in knowledge is bound to an acknowledged problem 
among renal transplant recipients and their healthcare teams – a lack of 
compliance with recommended medical regimens. Our argument here is that 
an exploration of patient intimacy with transplant-related immunosuppression 
might illuminate a different understanding of this experience that could 
enhance health professionals’ understanding and their subsequent approach 
to treatment. We contend that the embodied and contextual experience of the 
patient needs to be equally valued in order to enhance patient outcomes.
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Introduction: Biomedical perspectives of renal
transplantation and immunosuppression
From the biomedical perspective, transplantation is the ‘transfer of living 
cells, tissues or organs from a donor to a recipient, with the intention of 
maintaining the functional integrity of the transplanted material in the 
recipient’ (Merck manual, 2006a). Renal transplantation, which involves 
the grafting of either live or cadaveric kidneys into a recipient body, is the 
treatment of choice for individuals in end-stage renal failure. This procedure 
obviates the time-consuming, lifestyle-constricting and costly dialytic 
procedures that are otherwise necessary to clear the body of accumulated 
wastes in the absence of functioning kidneys.
From the perspective of health professionals working in the area of organ 
transplant, ‘survival’ following renal transplantation is dependent on the 
host body accepting the donated ‘alien’ tissue. Such acceptance relies on 
the inhibition of the body’s immune reaction to prevent the rejection of the 
donated kidney. This pharmaceutically induced suppression of physiological 
difference between host and donor, has made organ transplantation a 
viable treatment. The judicious use of immunosuppressive drugs, coupled 
with constant immunological surveillance of kidney recipients for the life 
of the donated organ, has resulted in standard renal transplant survival 
rates of between 70 and 90 per cent one year after transplant (Merck 
manual,  2006c). There have also been reports of functioning grafts up to 
30 years after the procedure (Merck manual, 2006c). In theory, the dosage 
of immunosuppressive agents is delicately balanced between selective 
repression of the immune system to ensure graft survival, and ensuring some 
degree of immune protection against disease. The obvious and unfortunate 
consequence of this practice, however ﬁ nely tuned, is the immunosuppressed 
body inevitably becomes open to infections and diseases that can lead to 
the death of transplant recipients (Brenner et al., 2002; Merck manual, 
2006b). Some of these drugs also have considerable toxicities that are not 
well tolerated by patients. Their side-effects include, but are not limited 
to, oedema, systemic hypertension, hyperlipidemia, diabetes, mood and 
sleep alteration, high blood pressure, renal insufﬁ ciency, infection, obesity, 
osteoporosis, gastric ulcers and various malignancies (Sherwood, 1993; Burke, 
2003; Green, 2003; Fireman et al., 2004). Inherent in the great care taken to 
balance these issues is recognition that the post-transplant recipient teeters 
continuously and precariously between organ rejection and infection.
Understandably, given the acknowledged biomedical focus on main-
taining the functionality of transplanted material in the organ recipient (Merck 
manual, 2006d), the compliance of patients to a medical regimen for graft 
preservation is of constant concern to health professionals. Renal patients 
in general are not notable for their compliance with pre-transplant medi-
cal regimens, let alone post-transplant medical regimens. Unsurprisingly,
non-compliance is the most commonly cited reason for graft failure 
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(Chisholm et al., 2001; Kreiger and Emre, 2004; Moloney et al., 2005). We 
believe that there are two reasons for this.
First, the patient’s understanding of the immune system is largely ﬁ ltered 
through the lens of biomedical science, involving macrophages, antibody-
antigen complexes, renal insufﬁ ciency and disturbed metabolisms. This 
complex language is fashioned from a closed biomedical ﬁ eld by select 
practitioners who work in that ﬁ eld. Like the immune system, renal systems 
are biomedical constructs, assembled and maintained through biomedical 
knowledges and technologies (Haraway, 1991). This establishes a strict 
boundary between transplant science and the patient, with scientiﬁ c 
knowledge often provided to the patient in a supposedly attenuated, easily 
digested form by the healthcare professional. The aim is to provide some 
kind of scientiﬁ c and medical literacy to enhance patient compliance to 
medical regimens. Additionally, patients and the lay public are ‘educated’ 
on science and medicine through the media. The media and their portrayal 
of these issues is an extremely important source of public information, but 
one that does not necessarily provide a comprehensive picture. Hence, in 
this initial framework, compliance is related to patient levels of knowledge 
and understanding. We will return to this later.
Second, and most importantly, while these biomedical discourses are valid, 
there is more to the experience of transplant-related immunosuppression 
and adherence to medical regimen than ‘graft survival’. This connects to the 
lived experience of ‘being’ an immunosuppressed body. The literature on 
this is sparse, though sociologists and anthropologists of biomedicine have 
come some way to providing some understanding. In the process, they have 
provided invaluable insights that might enhance clinicians’ comprehension 
of what it means to adhere to immunosuppressive regimens. This article 
explores these issues in terms of the immune system and the maintenance 
of social order; and the post-transplant body. It should be noted that this 
exploration is a theorization of existing literature. In the future, we plan 
to expand this to an empirical examination. The aim of our analysis here 
is to indicate signiﬁ cant gaps in the ﬁ eld, which, we believe, compromise 
the treatment and care of individuals who experience a compromised 
immune system, particularly post-transplantation. Empirical research is 
particularly lacking with respect to embodiment and the subjective, private 
post-transplant body. As such, this article covers signiﬁ cant ground, drawing 
attention to the complexities of transplantation, immunosuppression and 
compliance; a complexity that is heightened by tensions that may exist 
between the social, biological and material bodies.
The immune system and the maintenance of social order
There have been numerous sociological and anthropological explorations 
of the healthy immune system (for example, Haraway, 1991; Martin, 1994). 
While none of these studies focus speciﬁ cally on immunosuppressed renal 
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transplant patients, they are none the less useful for our present purposes. 
This is because they expose the biomedical discourse of the immune system 
as saturated with aggressive and coercive imagery, which may inﬂ uence the 
way healthcare professionals and patients alike approach post-transplant 
medical regimens. Additionally, these examinations highlight strong omis-
sions in our understandings of immune system ‘experiences’.
In Western thought, social order has long been a signiﬁ cant concern, 
and the healthy body has often functioned as a metaphor for a politically 
healthy society. The body operates as a robust image for social pathology, 
as it represents the structure and function of society as a whole (Otis, 1999; 
McCarthy, 2005). The discourse of the immune system provides the analyst 
with a particularly rich ﬁ eld in this respect. Martin (1994), for example, 
describes how the media position the immune system as the chief defender 
of the body. In such frameworks, the body is articulated as a machine, with 
the immune system maintaining and preserving the sanctiﬁ ed police-state 
or nation-state of the body. In these discourses, three consistent socio-
political themes emerge: martial imagery and the requirement for internal 
bodily surveillance and policing; the body as a regulatory communications 
network; and the hierarchy of labour divisions to maintain nation-state 
integrity. These categories provide a coherent framework that affords 
some understanding of how the immune system has been constructed and 
how the immunosuppressed renal transplant recipient may interpret and 
understand their own situation. We will now examine these socio-political 
themes in turn.
Martial imagery
The body is consistently portrayed by the media and healthcare professions 
as a revered nation-state vulnerable to the threat of the ‘foreign’, as 
embodied in the ‘other’ (Martin, 1994). Strict borders are drawn between 
self and non-self, which are patrolled and protected by a hyper-alert immune 
system. In these portrayals, the body is a martial nation-state at war with 
hostile and polluting agents. Constant vigilance, defence and retaliation are 
the obvious responses to non-self entities that dare to invade the body’s 
external borders. Dwyer (1993), writing from the biomedical perspective, 
draws on this imagery repeatedly. For Dwyer, the immune system consists 
of a series of security systems, forces and checkpoints, which protect ‘the 
sacrosanct environment of a body’ (1993: 33). These self-preservation 
techniques additionally involve metaphors such as guard dogs, barbed wire, 
spotters, bouncers and identity checks (Dwyer, 1993). Every native cell in 
this policed body is equipped with a proof of identity that protects it against 
attacks from the body’s own defence mechanisms, while intruder ‘records’ 
are stored in the vast archives of the immune system’s memory cells (Dwyer, 
1993; Martin, 1994). The potency of this imagery is reinforced by the section 
titles of Dwyer’s (1993) text, including ‘The War and the Warriors’, ‘Taming 
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the Warriors’, ‘The Defeat of the Warriors’, ‘Where are the Generals?’ and 
‘Assisting the Warriors’. The brutal power of this metaphorical discourse is 
perhaps no more vivid than in the following:
Quite destructive soldiers, kept for this purpose [to deal with an ‘intruder’ 
demonstrating ‘destructive behaviour’], would seize upon the hapless violater 
[sic] and kill him with a combination of chemicals and repeated stabbings – the 
security business is not a pretty one. (Dwyer, 1993: 35)
Communication networks
In addition to these martial metaphors, Martin’s (1994) analysis also makes 
it clear that this nation-state is not controlled by one organ alone. It is a 
‘kind of biologic democracy, wherein the individual members achieve 
their ends through an information network of awesome scope’ (Jaret, 1986 
in Martin, 1994: 415). The role of communication in this nation-state is 
paramount. The immune system takes on this role, operating as the body’s 
regulatory communications network: a sophisticated and ﬂ uid conﬁ guration 
of command-control-communication-intelligence (C3I) (Haraway, 1991; 
Martin, 1994). The cunning speciﬁ city of this network means intruders who 
do not speak the language are subject to mechanisms of control through 
extermination. Hence, the immune system’s communicative role of 
identifying self and other is vital for the militaristic immune activities. In this 
fashion, ‘the immune system is a plan for meaningful action to construct and 
maintain the boundaries for what may count as self and other in the crucial 
realms of the normal and the pathological’ (Haraway, 1991: 204). Martin 
(1994) argues the outcome of this is a discourse permeated with imagery of 
force and control, which in effect domesticates violence and makes aggression 
seem an ordinary and natural part of daily life. We would argue that this 
aggression and violence also justiﬁ es the severity of many medical practices in 
immunosuppression and transplantation. In turn, such approaches heighten 
the medical construction of body-as-machine (the disembodied object) in 
preference to the body-as-self (the embodied subject).
Labour divisions
All nation-states, including bodily democracies, tend effectively to function 
primarily through hierarchical divisions of labour. In immune system 
discourses constructed by the media and biomedicine, these hierarchies 
tend to be informed by the traditional, stereotypical gender differences of 
the wider body politic (Martin, 1994). This includes performing work often 
associated with the masculine ethos of the clinic. Thus, as Martin (1994) 
demonstrates, the T- and B-cells, which are positioned in these discourses 
at the apex of the immune system hierarchy, are portrayed as masculine. 
Their war-like actions include killing intruders through phallic activities 
of penetration and injection. T-cells are also posited as highly specialized, 
tactical and almost intellectual entities, who orchestrate the defensive system 
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and store memories of past enemies for future reference (Martin, 1994). 
In contrast, lower-ranking members of the hierarchy, such as phagocytes 
and macrophages, assume a distinctly feminine cast (Martin, 1994). Their 
feminine work, which reﬂ ects the labour of household maintenance,  involves 
the drudgery of cleaning up or engulﬁ ng foreign particles (Martin, 1994). 
They are also stereotypically female and motherly in their self-sacriﬁ ce on 
behalf of bodily integrity when confronted with threatening invaders. The 
longstanding association of the female and the uncivilized that has been 
well explicated in feminist theories (for example, see Birke, 1994; Birke et 
al., 2004; McCarthy, 2005) is also evident in immune system discourse that 
describes their other lower order function of cannibalizing dangerous parts 
of the self.
These biomedical portrayals of the immune system as a violent and 
gendered communication network may place the renal patient, who has 
their immunosuppression induced as a life-saving measure, in an ambiguous 
position. For example, one individual in Martin’s study visualized the 
immune system as an attacker, designed to protect the body’s boundaries 
from external assault: ‘your body is going to get ready to defend itself and 
destroy the bad stuff, the bad guys’ (1994: 177). When given the opportunity, 
however, individuals may employ other imagery, particularly related to the 
more benign aspects of political networks. This includes metaphors of ﬂ ow 
and ﬂ ux that predicate the immune system as a constant that is everywhere 
and nowhere in the body; a responsive agent that is subject to variation and 
change (Martin, 1994). Therefore, while the lay person may not have a purely 
biomedical understanding of the immune system, they can demonstrate an 
understanding of its complexities and ambiguities. In other words, while 
their comprehension is not framed by rigid biomedical ‘fact’,  they do have an 
understanding that involves complex human issues and expertise (Claeson 
et al., 1996). The public account and negotiation of illness, however, can be 
different to private accounts of experiencing illness. Importantly, the way 
people engage in this ‘talk’ is vital for the bodily experience of self (Kelly and 
Field, 1996). Thus, it is reasonable to surmise that the immunosuppressed 
individual may have their own ways of understanding the immune system, 
which are beyond medical understandings of immune system biology, and 
are inﬂ uenced by their own experiences, knowledges of and interactions 
with the world (Claeson et al., 1996).
While these studies are fascinating explorations of immune system 
perceptions, they are mostly conceptualized by those who are neither trans-
plant recipients nor immunocompromised. This highlights a signiﬁ cant gap 
in knowledge. Namely, we are missing perceptions and possible ambiguities 
of the medically–altered immune system by those who intimately experience 
its functions and alterations. We do not know how immunocompromised 
individuals understand or construct the immune system, let alone how they 
understand and construct their bodies in the immunosuppressed state. Such 
individualized negotiations and embodied experiences are undoubtedly 
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signiﬁ cant for the healthcare profession and professional. This knowledge 
gap may compromise patient treatment and their quality of life. A major 
problem in current knowledge therefore is a lack of empirical research. What 
this also highlights is that while it is important to understand how people 
who are immunocompromised view the immune system, it is also important 
to understand their diverse relations and the contextual experiences of 
their embodied selves in such a state. Consequently, we wish to explore the 
literature detailing the possible challenges in living with a post-transplant, 
immunosuppressed body. This is divided into two concerns: the objectiﬁ ed 
and medicalized body; and the subjective and private body. The ﬁ rst point 
relates to how medicine understands the post-transplant body, which is often 
framed around compliance rhetoric. The latter, with a focus on the ‘lived’ 
social and material body is often viewed in direct opposition, though no 
existing literature speciﬁ cally deals with these issues. These considerations 
illustrate a complex network of immunosuppression, transplantation, 
compliance and contextual experiences of the body. Again, we focus on 
a theoretical examination of existing literature in order to emphasize the 
shortcomings in existing knowledge.
The objectiﬁ ed and medicalized post-transplant body
As noted previously, post-transplant immunosuppression may cause 
signiﬁ cant side-effects for the patient,  such as infection and treatment-related 
disease. Pharmaceutically induced immunosuppression can therefore create 
further health problems or exacerbate existing ones, which may adversely 
affect quality of life and familial relationships. Such experiences highlight 
complex psychosocial problems associated with pre- and post-transplant 
adjustments, which include lifestyle adaptations that can alter relations 
between self, family and others (Rauch and Kneen, 1989). In addition, 
complex emotions accompany the wait and the receipt of a donated organ. 
These emotional states, which can be exacerbated by immunosuppressive 
drugs, have led to over 50 per cent of transplant recipients reporting mood 
changes, adjustment disorders, depression, post-traumatic stress, delirium 
and psychiatric problems (Rauch and Kneen, 1989; Fukunishi et al., 2001; 
Jowsey et al., 2001; Dew et al., 2004).
Due to these numerous post-transplant challenges, it is not surprising 
that psychosocial and clinical research is primarily concerned with 
understanding those aspects believed to inﬂ uence directly the patient’s 
post-transplant quality of life, namely patient non-compliance with medical 
regimens. The enormous amount of literature on these topics indicates their 
intense interest to healthcare researchers and providers (Martins, 2005). 
We will now brieﬂ y explore a small selection of this research.
As stated previously, renal patients are not noted for compliance with 
pre- or post-transplant regimens. In general, patient non-compliance 
with rigorous medical regimens and lifestyle changes are believed to be 
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prevalent in post-transplant recipients (Jowsey et al., 2001), with Laederach-
Hofmann and Bunzel (2000) reporting a 20–50 per cent non-compliance 
rate. As a result, the issue of patient compliance with medical regimens, 
which is variously referred to as adherence, commitment or concordance, is 
among the most voluminous,  yet least understood, in renal and transplant 
literature. Compliance research centres on patient behaviours that increase 
infectious risk or pose a threat of transplant rejection. For example, Donovan 
et al. (2004) found that despite an increased risk of immunocompromised 
post-transplant recipients developing skin cancer, only 18 per cent of 205 
transplant recipients practise adequate levels of sun-protective behaviours, 
with 23 per cent continuing to seek a suntan. Consequently, ‘between 35–
50% of transplant recipients will develop one or more skin cancers by the 
tenth year following organ transplantation’ (Donovan et al., 2004: 1852).
Generally, ‘transplant patients tend to be divided into those who  comply with 
the treatment regime and those who do not’ (Baines et al., 2005: 43). In order 
to identify and circumvent patient non-compliance post-transplantation, 
Wilkins et al. (2003) advocate holistic approaches focused on patient survival, 
rather than graft survival. In this approach, patient empowerment is fostered 
by building relationships with healthcare professionals and through targeted 
education programmes. It is argued this facilitates a return to normalcy, 
which, by default, promotes graft endurance (Wilkins et al., 2003). Similarly, 
Bunzel and Laederach-Hofmann (2000), Levenson and Olbrisch (2000) and 
Baines et al. (2005) believe patient non-compliance with medical regimens 
can be identiﬁ ed, circumvented or interceded through detection methods 
such as psychosocial proﬁ ling or screening. It is claimed these interventions 
are holistic, providing education and psychological support so patients 
can demonstrate their ability to comply pre-transplantation (Bunzel and 
Laederach-Hofmann, 2000; Levenson and Olbrisch, 2000), or to shift their 
behaviour towards compliance and emotional stability post-transplantation 
(Baines et al., 2005). We would argue, however, that these interventions 
are framed around subjective and ambiguous judgements on behalf of 
the healthcare profession. For example, it is pre-determined ‘whether the 
patient can be sufﬁ ciently educated for the transplant patient role’, and ‘will 
be able to form a collaborative relationship with physicians and comply with 
the medical regimen’ (Levenson and Oblrisch, 2000: 23).
In these frameworks, patient non-compliance is perceived as an adaptive 
challenge that requires medical intervention through active patient co-
operation. Educational programmes are aimed at creating psychosocial 
adjustment so that the patient will accept and deal with their immuno-
suppressed post-transplant condition in what is deemed to be an appropriate 
medical manner. This may involve psychological counselling. Hence, non-
compliance is reframed as a mental illness. Furthermore, as patient non-
compliance is viewed as a waste of precious resources, reasons for patient 
non-compliance are continuously sought. As a result, recent research has 
attempted to identify variables that lead to patient non-compliance to 
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circumvent or predict the need for medical intervention. For example, Bunzel 
and Laederach-Hofmann (2000) identify non-compliance as determined by 
demographic and psychological variables, psychiatric disorders, poor social 
support, obesity, substance abuse and health-related factors. Irrespective 
of patient control over any of these variables however, failure to comply 
is often directly or indirectly placed on the patient, who is ultimately held 
responsible for medical non-compliance and any associated behaviours.
Regardless of the intervention strategy adopted, these are often not very 
effective in increasing compliance rates. As indicated previously, patient 
non-compliance is a commonly reported problem in pre- and post-transplant 
recipients by healthcare professionals. Generally, patients are well informed 
and knowledgeable about their medications and the consequences of 
their actions (Laederach-Hofmann and Bunzel, 2000), meaning education 
programmes targeted at producing or enhancing compliance could be 
viewed as nonsensical. Patient non-compliance may have nothing to do 
with adherence to or the difﬁ culties of medical regimens. For example, the 
individual might be asserting themselves in the face of medicalized control 
and power. Perhaps part of this continued healthcare professional impulse 
to counter patient non-compliance arises from biomedical militaristic 
metaphors of the immune system and the body as nation-state. Shildrick 
argues the ‘issue of vulnerability, of controlling and eliminating the risk of 
weakness, … marks the immunocompromised body as a shortcoming’  (2001: 
156). From this perspective, immune deﬁ ciency marks the transplant patient 
as not only vulnerable but abnormal, operating contrary to the biological 
and societal standards of the nation-state. In other words, the threat of an 
immunosuppressed body lies in the transgression of boundaries, ‘in being 
irreducibly other to the binary self’ (Shildrick, 2001: 159). The irony for the 
immunocompromised renal transplant recipient is their immunodeﬁ ciency, 
their ‘abnormality’, is deliberately induced to ensure graft survival and their 
survival.
Despite extensive research, which has mostly been deﬁ ned in clinical 
terms, reasons for patient non-compliance are difﬁ cult to identify. It is our 
argument that this lack of biomedical understanding is partially linked 
to a failure to acknowledge subjective embodiment, as experienced by 
the patient. In other words, the ambiguity of the post-transplant immuno-
suppressed body has not been explored from the patient’s perspective and 
their own embodied experiences and negotiations of this state.
The subjective and private post-transplant body
Our explorations have now brought us to this point – what is missing 
from this biomedical network of transplantation, immunosuppression and 
compliance? We believe the answer is the most important voice of all – that 
of the patient. While it may be argued the patient’s experiences have been 
heard through medicalized discourses of quality of life and non-compliance, 
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the issue is not that straightforward. Namely, what we have is a network of 
biomedical discourse wherein the patient, their experiences, their survival 
and their life, are simplistically relegated to compliance or non-compliance 
with medical regimens. Thus, work undertaken to date approaches the issue 
of patient compliance almost exclusively from the clinician’s perspective, 
deﬁ ning it in terms that are important to the healthcare professional rather 
than the patient. Few studies in the entire health corpus have explored the 
subjective notion of compliance from the patient’s point of view. Therefore, 
despite extensive compliance literature, the voice of the immunosuppressed 
patient and the socio-cultural context in which they are embedded is 
noticeably absent. We plan to rectify this situation in our future research. For 
now, however, we would like to explore some sociological understandings 
of the subjective, embodied experience. While this literature does not 
focus explicitly on the post-transplant, immunosuppressed body, this 
initial theoretical analysis will provide some insight into how it might be 
understood and contextually experienced.
The debate about the terminology used with respect to patients’ alignment 
to medical discourse highlights the focus that has been placed on clinician 
understanding of the concept, rather than that of the patient. In their work, 
Laederach-Hofmann and Bunzel (2000) suggest the terms ‘compliance’ and 
‘adherence’ often indicate an unequal relationship between the doctor and 
patient, where the patient is viewed as passive and solely responsible for any 
behaviour that contravenes medical advice. This dichotomous relationship 
is based upon power and control (Baines et al., 2005). In recognition of this 
imbalance, the terms ‘concordance’ and ‘non-concordance’ have recently 
been posited by the healthcare profession as more desirable, suggesting 
doctor–patient consensus and patient empowerment rather than patient 
failure. For Laederach-Hofmann and Bunzel (2000), however, ‘compliance’ 
does not subvert the patient, as it implies a certain knowledge and awareness. 
In this conception, patient non-compliance cannot rest solely on the patient’s 
shoulders, as compliance is measured in relation to patient behaviour that is 
consistent with a ‘required and necessary’ medical regimen (Barber, 2002).
We dispute these assertions and again point to shortcomings in com-
pliance and adherence-based research. Even if patient compliance with 
medical regimens is concerned with health knowledge, this knowledge 
is viewed only in biomedical terms. For example, if the patient fails to 
take their imm-unosuppressive drugs regularly, their ‘non-compliance’ is 
interpreted as self-irresponsibility in choosing ‘certain death’ over ‘certain 
life’. As our examinations demonstrate, patient non-compliance with medical 
regimens indicates to the healthcare professional a need for biomedical 
education, which will enable them to become an autonomous agent aligned 
with biomedical discourses. Consequently, the focus remains on patient 
behaviour; their failure to change and adhere to medical regimens; and the 
consequent negative outcomes perceived to result from such irresponsibility. 
Hence, medical compliance, patient empowerment and autonomy and their 
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quality of life, are predicated upon a medicalized model of self-regulation, 
which, as deﬁ ned and mediated by medical expertise, is accorded the highest 
importance.
While the reasons health professionals have positioned patient behaviour 
in these ways are understandable, such an approach fails to recognize the 
patient’s own perceptions, knowledge and experiences. Here, a conﬂ ict 
between the individual (subject) and the biomedicalized (object) body 
arises. Namely, patient non-compliance in the biomedical framework 
is viewed simplistically as medicinal, behavioural and attitudinal, and 
undervalues the complex multiplicities of difference that patients bring 
to biomedical encounters. In other words, patient non-compliance is 
medicalized through interventionist strategies, even though patient non-
compliance may have no connection to medicine or their own health. Thus, 
the provision of healthcare should be a multidimensional process between 
the healthcare professional, the institution and patient, where each, and 
not just the renal transplant recipient, may need to adapt and change their 
expectations to facilitate a mutually desirable outcome. This approach may 
also highlight the ways in which patient compliance and non-compliance 
are socially constructed through a narrowed lens of biomedical knowledge, 
regimens and procedures. We have argued earlier that patient compliance 
with prescribed medical regimens may diminish or compromise quality of 
life and the lived body. By understanding compliance through lenses other 
than biomedical frameworks, we can see that compliance literature is not 
actually concerned with patient compliance as such. It is about power and 
control, and where these are most appropriately located. By focusing on 
patient insufﬁ ciencies and a patient’s need for education and change, it 
is evident that the healthcare profession believes that power, knowledge 
and control are best located in the hands of the biomedical establishment 
and healthcare professionals. Patient autonomy is subsequently judged as 
either positive or negative and is based upon their behavioural relationship 
to medicalized control, which serves to continually produce and reproduce 
the rhetoric of good (compliant) and bad (non-compliant) patient. We will 
return to these points soon.
With these considerations in mind, we agree with Martins that both 
adherence and compliance, ‘judge the patient behavior in ways that carry 
detrimental consequences for the patient and … fail to engage a more 
robust notion of context’ (2005: 75). In addition, the desire for patient 
compliance with medical regimens presumes agency and autonomy in 
the role of patient. This is not the case. Rather, patient compliance with 
medical regimens involves an individual’s sacriﬁ ce of life (Martins, 2005), 
body, self and identity. These sacriﬁ ces occur by resigning knowledge 
and control to the medical ‘other’ (Martins, 2005). As a result, power is 
withdrawn from the individual, who is simply reduced to being a biologically 
immunocompromised and post-transplant body. In other words, the desire 
of the healthcare profession for patient compliance is only concerned with 
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an objectiﬁ ed and medicalized body, and not the subjective experience of 
lived embodiment. The ability to decide one’s own quality of life, including 
self-sacriﬁ ce and self-determination, is generally not considered. That is, 
patient compliance with post-transplant medical regimens could, from the 
patient’s perspective, compromise their quality of life rather than enhance 
it. It is not surprising that patients are ‘non-compliant’ when their social and 
embodied human lives are disregarded in such a reductionist manner.
Signiﬁ cantly, these studies on the experience of immunosuppression 
also focus exclusively on the body as static. The inference is that the 
body is unchangeable and operates simply as a protective boundary from 
outside inﬂ uences. Therefore, what is external to the body is perceived as a 
dangerous threat, which the immunocompromised individual needs to deal 
with by complying with a medical regimen. Non-compliance, as the antithesis 
of compliance, is viewed as choosing death over life; the pathological 
over normal; illness over health; and the undesirable over the desirable. 
These medicalized dichotomies, however, are not necessarily the everyday 
embodied reality of the patient. Rather, the relationship between the immune 
system and the body is complicated and ambiguous, intimately involving 
things external to the body on an everyday basis other than infectious 
‘threats’. When one considers the experience of immunosuppression, these 
complexities could be numerous. For example, accepting a foreign renal graft 
involves blurring the self and other. This experience is heightened further 
through natural and unnatural transgressions in immunosuppression. With 
or without the immunocompromised experience, however, the body is ﬂ uid 
and open to the outside world (Martins, 2005). Therefore, the everyday 
‘lived’ reality of embodiment blurs biomedical hierarchical binaries. At the 
same time, we do not know if immunocompromised transplant recipients 
actually experience their bodies in this fashion.
While biomedical interventions and technologies have destabilized the 
individual body and privileged the biomedical and objectiﬁ ed body, the 
post-transplant body remains attached to individual people as subjects, 
who need to negotiate and manage the biomedical discourse in which they 
are now embedded. As mentioned previously, this management occurs in a 
particular socio-cultural context, and not simply in a biomedical framework. 
In particular, the meanings of immunosuppressed bodies produced by 
biomedical technologies and ‘experts’ are not necessarily meaningful or 
recognizable to the renal transplant patient, as biomedical interventions 
may construct the individual in ways that do not align with the patient’s 
self-recognition and their embodied, lived experience.
In asserting the body as a social phenomenon however, we are not ignoring 
that the body has a biological component. Rather, bodies are social, material 
and biological constructions, and biomedicine has a socially acknowledged 
position in understanding the medically altered body. Therefore, meanings 
attributed to bodies by medical technologies and individual experiences 
of illness are crucial in the construction of self and social identity (Kelly 
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and Field, 1996), meaning the body can be experienced simultaneously 
as a medicalized object and an embodied subject. This multiple and 
complex nature of self and identity illustrates that the attention of health 
professionals should not be simplistically focused on the biological body, 
where the current aim is to align patients to biomedical discourses. In turn, 
sociologists should not be solely concerned with the social and material body. 
Rather, we need understandings of how and when the post-transplant and 
immunosuppressed body is experienced individually as object and subject, 
and when it is experienced simultaneously as object and subject. In other 
words, we need both a sociological and medical framework in which both 
the biological and social bodies are considered. Through such an approach, 
we need also to explore how these complexities intersect with the various 
complexities and understandings of being an immunosuppressed, post-renal 
transplant recipient.
Conclusion
The goal of kidney transplantation is to improve the quality of life of 
patients in chronic renal failure. Nonetheless, renal recipients must make 
enormous lifestyle changes to maximize their chances of survival and good 
health while undergoing lifelong immunosuppression. From a healthcare 
perspective, this includes patient compliance with medical regimens. As we 
have explored, biomedical discourse on patient compliance universalizes 
and mechanizes the body and its experiences, ignoring multiplicity, 
complexity and context. In addition, compliance rhetoric only targets 
one body – the biological body as diagnosed through  and determined by 
medical expertise and technologies – and undermines the material and 
social body. This dualistic and hierarchical structure of privilege can only 
understand the body as a manipulative object, which can be rendered as 
obedient through appropriate medical manipulation and intervention 
via the healthcare professional. This medicalized approach to the body, 
however, fails to understand how immune systems, immunosuppression 
and transplantation are lived experiences of subjective embodiment. 
It is necessary that healthcare professionals maintain awareness of the 
individuals who have their own views, negotiations and practices of 
their complex body, without an impetus to ‘intervene’ or ‘instil change’ 
in patient behaviour. The reduction of the body to a biological and 
mechanistic object in need of ‘expert’ intervention does a great disservice 
to all concerned in renal transplantation.
Our argument here is that becoming a renal transplant recipient and 
subsequently being immunosuppressed involves the adoption of norms and 
an acceptance of judgements that often do not originate with the individual 
concerned. For those labelled as ‘non-compliant’, medical regimens may be the 
imposition of normative ideals and practices through a biomedically mediated 
framework for self-care behaviour which the patient may not identify with.
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We want to look at the competing forces enacting on and of the body, and 
the contexts in which these occur. We acknowledge the close relationship 
between the lived experience of the social, biological and material body, 
and understand these are important in identity construction and a patient’s 
everyday reality. In the words of Shildrick, ‘corporeal and ontological anxi-
ety [sic] are inseparable’ (2001: 159). We want to understand the immuno-
suppressed body as a lived and embodied experience, not simply as a 
conceptual or theoretical undertaking which unfortunately, due to the lack 
of empirical research, we have been restricted in doing here. It is necessary 
to ‘capture how people live the discourse … (to view) people’s bodies as 
meeting places for different ﬁ gures of thought and practices’ (Lundin, 1999: 
5). When biological boundaries such as immune systems are blurred or 
effaced, ‘then normative boundaries and individual self images’ (Lundin, 
1999: 6) are also renegotiated. Not only is the material body complicated, 
so is the biological body. Therefore, through our future research, we seek to 
understand the social, material and biological bodies in the post-transplant, 
immunosuppressed experience, and the intersections that exist between
them. We seek the delicate balance in the complex network of transplanta-
tion, immunosuppression and compliance. As such, we are not only concer-
ned with the ‘lived’ experiences and intricacies of the material and biological 
bodies, but also the complications that exist between them and the multiple 
contextual experiences of ‘being’ post-transplant and immunosuppressed. 
We believe that through such understandings, a common ground can be 
forged between the medical establishment and the immunosuppressed post-
transplant individual. We have set ourselves no easy task.
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